These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9387958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW, Micheletto C, Tognella S, Trevisan F, Guerriero M.
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL, Sammut PH, Judy CG, Colombo JL.
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo.
    Langley SJ, Masterson CM, Batty EP, Woodcock A.
    Eur Respir J; 1998 May; 11(5):1081-5. PubMed ID: 9648959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease.
    Dahl R, Earnshaw JS, Palmer JB.
    Eur Respir J; 1991 Nov; 4(10):1178-84. PubMed ID: 1687131
    [Abstract] [Full Text] [Related]

  • 18. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence of tachyphylaxis associated with salmeterol treatment of chronic obstructive pulmonary disease patients.
    Tsagaraki V, Amfilochiou A, Markantonis SL.
    Int J Clin Pract; 2006 Apr; 60(4):415-21. PubMed ID: 16620353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.